Your browser doesn't support javascript.
loading
On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
Okin, Peter M; Hille, Darcy A; Wachtell, Kristian; Kjeldsen, Sverre E; Julius, Stevo; Devereux, Richard B.
  • Okin PM; Division of Cardiology, Weill Cornell Medical College, New York, NY, USA.
  • Hille DA; Merck Research Labs, West Point, PA, USA.
  • Wachtell K; Department of Cardiology, Oslo University Hospital, Oslo, Norway.
  • Kjeldsen SE; Department of Cardiology, Oslo University Hospital, Oslo, Norway.
  • Julius S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Devereux RB; Division of Cardiovascular Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA.
Blood Press ; 29(5): 319-326, 2020 10.
Article en En | MEDLINE | ID: mdl-32586143
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atenolol / Fibrilación Atrial / Hipertrofia Ventricular Izquierda / Losartán / Hipertensión / HDL-Colesterol / Antihipertensivos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atenolol / Fibrilación Atrial / Hipertrofia Ventricular Izquierda / Losartán / Hipertensión / HDL-Colesterol / Antihipertensivos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article